Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $14.9 million.

  • Sanara MedTech's Cash & Equivalents fell 821.73% to $14.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.9 million, marking a year-over-year decrease of 821.73%. This contributed to the annual value of $15.9 million for FY2024, which is 20848.32% up from last year.
  • Sanara MedTech's Cash & Equivalents amounted to $14.9 million in Q3 2025, which was down 821.73% from $17.0 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Cash & Equivalents registered a high of $27.3 million during Q1 2021, and its lowest value of $2.8 million during Q1 2024.
  • For the 5-year period, Sanara MedTech's Cash & Equivalents averaged around $13.6 million, with its median value being $14.9 million (2025).
  • In the last 5 years, Sanara MedTech's Cash & Equivalents skyrocketed by 399623.05% in 2021 and then tumbled by 6118.5% in 2024.
  • Over the past 5 years, Sanara MedTech's Cash & Equivalents (Quarter) stood at $18.7 million in 2021, then tumbled by 51.97% to $9.0 million in 2022, then tumbled by 42.55% to $5.1 million in 2023, then soared by 208.48% to $15.9 million in 2024, then decreased by 5.91% to $14.9 million in 2025.
  • Its last three reported values are $14.9 million in Q3 2025, $17.0 million for Q2 2025, and $20.7 million during Q1 2025.